Tyrosine phosphorylation of Mdm2 by c-Abl: Implications for p53 regulation

EMBO Journal

Volumn 21, Issue 14, 2002, Pages 3715-3727

  Goldberg, Zehavit ^a   Sionov, Ronit Vogt ^a   Berger, Michael ^a   Zwang, Yaara ^a   Perets, Ruth ^a   Van Etten, Richard A ^a   Oren, Moshe ^a   Taya, Yoichi ^a   Haupt, Ygal ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

c Abl; Mdm2; p53; Tyrosine phosphorylation

Indexed keywords

ABELSON KINASE; DNA; ONCOPROTEIN; PHENYLALANINE; PROTEIN MDM2; PROTEIN P53; PROTEIN TYROSINE KINASE; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; STRESS; TRANSCRIPTION REGULATION;

AMINO ACID SUBSTITUTION; APOPTOSIS; CELL CYCLE PROTEINS; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ABL; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; TYROSINE;

EID: 0037099586     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdf384     Document Type: Article

References (73)

1. Interaction of c-Abl and p73ct and their collaboration to induce apoptosis
2. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
3. Regulation of p53 function and stability by phosphorylation
4. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation
5. Nuclear c-Abl is a COOH-terminal repeated domain (CTD)-tyrosine (CTD)-tyrosine kinase-specific for the mammalian RNA polymerase II: Possible role in transcription elongation
6. DNA damage induced p53 stabilization: No indication for an involvement of p53 phosphorylation
7. An intact Hdm2 RING-finger domain is required for nuclear exclusion of p53
8. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage
9. 1 arrest and apoptosis functions of the p53 tumor suppressor protein
10. Serinel5 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2
11. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line
12. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
13. A genetic approach to mapping the p53 binding site in the Mdm2 protein
14. The Mdm2 RING-finger domain is required to promote p53 nuclear export
15. The complexity of p53 modulation: Emerging patterns from divergent signals
16. p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase
17. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
18. Getting p53 out of the nucleus
19. Cross-talk between Akt, p53 and Mdm2: Possible implications for the regulation of apoptosis
20. Protein kinase CK2 interacts with a multiprotein binding domain of p53
21. The carboxy terminus of p53 mimics the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylation
22. Cell type-specific inhibition of p53-mediated apoptosis by Mdm2
23. Mdm2 promotes the rapid degradation of p53
24. Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains
25. Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells
26. ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
27. Pro-apoptotic effect of the c-Abl tyrosine kinase in the cellular response to 1-β-D-arabinofuranosylcytosine
28. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses
29. The many substrates and functions of ATM
30. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
31. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents
32. Determination of cell fate by c-Abl activation in the response to DNA damage
33. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage
34. Regulation of p53 stability by Mdm2
35. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs
36. ATM-dependent phosphorylation of Mdm2 on serine 395: Role in p53 activation by DNA damage
37. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
38. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53
39. Mdm2 deletion does not alter growth characteristics of p53-deficient embryo fibroblasts
40. Mechanisms of switching on p53: A role for covalent modification?
41. The p53 and Mdm2 families in cancer
42. MDM2-master regulator of the p53 tumor suppressor protein
43. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination
44. Stimulation of p53 DNA binding by c-Abl requires the p53 C-terminus and tetramerization
45. Regulation of the p53 tumor suppressor protein
46. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation
47. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein
48. The nuclear tyrosine kinase c-Abl negatively regulates cell growth
49. Interaction between ATM protein and c-Abl in response to DNA damage
50. c-Abl: Activation and nuclear targets
51. The ARF/p53 pathway
52. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
53. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization
54. ATM and ATR: Networking cellular responses to DNA damage
55. A leucine-rich nuclear export signal in the p53 tetramerization domain: Regulation of subcellular localization and p53 activity by NES masking
56. Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species
57. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53
58. Engineering the substrate specificity of the Abl tyrosine kinase
59. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2
60. Cycling, stressed-out and nervous: Cellular functions of c-Abl
61. The cellular response to p53: The decision between life and death
62. c-Abl neutralizes the inhibitory effect of Mdm2 on p53
63. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination
64. The regulation of p53 growth suppression
65. The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products
66. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53
67. MDM2-dependent ubiquitination of nuclear and cytoplasmic p53
68. Genotoxic drugs induce interaction of the c-Abl tyrosine kinase and the tumor suppressor protein p53
69. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage
70. Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase
71. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage
72. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation
73. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation